Brookline Bancorp Inc

Aktienanalyse zu Brookline Bancorp Inc (BRKL)

$24.086

-0.190 (-0.79%)Zum Schluss

Loading chart…
High
24.380
Open
24.380
VWAP
24.18
Vol
233.00
Mkt Cap
751.16M
Low
24.086
Amount
5.63K
EV/EBITDA, TTM
0.00

Brookline Bancorp, Inc. operates as a division of Beacon Bank & Trust . The Bank offers a range of commercial, business and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans and investment services, designed to meet the financial needs of small-to mid-sized businesses and individuals throughout Central New England and the Lower Hudson Valley in New York. Its specialty lending activities, including equipment financing, are focused on the New York and New Jersey metropolitan area, with services offered throughout the United States. Its loan portfolio consists primarily of first mortgage loans secured by commercial, multifamily and residential real estate properties located in the Company's primary lending area, loans to business entities, including commercial lines of credit, and loans to condominium associations.

Analyst Ratings (5)

-47.06% downside
Hold
2 Buy
3 Hold
0 Sell
Current: 24.09
Tief
12.50
Durchschnitt
12.75
Hoch
13.00

Keefe, Bruyette & Woods

2024-12-24

Kursziel

$15

Hold

Raymond James

2024-12-20

Kursziel

$16

Strong Buy

Keefe, Bruyette & Woods

2024-12-04

Kursziel

$15

Buy

Keefe, Bruyette & Woods

2024-07-26

Kursziel

$11

Hold

Keefe, Bruyette & Woods

2024-04-26

Kursziel

$11

Hold

Bewertungskennzahlen

The current forward P/E ratio for Brookline Bancorp Inc (BRKL) is 11.38, compared to its 5-year average forward P/E of 10.22.

Forward P/E

Fair
5Y Average P/E
10.22
Current P/E
11.38
Überbewertet
12.46
Unterbewertet
7.98

Forward EV/EBITDA

Strongly Undervalued
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Überbewertet
0.00
Unterbewertet
0.00

Forward P/S

Fair
5Y Average P/S
2.65
Current P/S
2.02
Überbewertet
3.42
Unterbewertet
1.88

Alphio AI Price Scenarios for BRKL

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%BRKL

$18.71

Szenariopreis

B

Base

Base · 50%BRKL

$16.04

Szenariopreis

B

Bear

Bear · 25%BRKL

$13.74

Szenariopreis

Event-Zeitleiste

2025-09-02 (ET)

04:55:00

Sarepta to Take Brookline Bancorp's Place in S&P 600 Starting September 2nd

2025-08-26 (ET)

17:28:30

Sarepta to Take Brookline Bancorp's Place in S&P 600 Starting September 2nd

2025-08-25 (ET)

16:10:42

Regulatory Approval Granted for Berkshire Hills Bancorp and Brookline Bancorp Merger

16:09:42

Regulatory Approval Granted for Berkshire Hills Bancorp and Brookline Bancorp Merger

2025-07-23 (ET)

16:27:59

Brookline Bancorp reports Q2 EPS 25c, consensus 25c

News

BRKL FAQ — answered by Alphio AI

Brookline Bancorp, Inc. operates as a division of Beacon Bank & Trust . The Bank offers a range of commercial, business and retail banking services, including a full complement of cash management products, online banking services, and consumer and residential loans and investment services, designed to meet the financial needs of small-to mid-sized businesses and individuals throughout Central New England and the Lower Hudson Valley in New York. Its specialty lending activities, including equipment financing, are focused on the New York and New Jersey metropolitan area, with services offered throughout the United States. Its loan portfolio consists primarily of first mortgage loans secured by commercial, multifamily and residential real estate properties located in the Company's primary lending area, loans to business entities, including commercial lines of credit, and loans to condominium associations. It operates in the Financials sector (SAVINGS INSTITUTION, FEDERALLY CHARTERED industry).

5 analysts cover BRKL: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 12.75.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten